课题基金 / 基金详情

Role of CD8+ dendritic cells in antigen (cross-) presentation and cytotoxic immunity of the mouse and the human

Role of CD8+ dendritic cells in antigen (cross-) presentation and cytotoxic immunity of the mouse and the human
CD8 树突状细胞在小鼠和人类抗原(交叉)呈递和细胞毒性免疫中的作用
批准号:
173831869
负责人:
Professor Dr. Richard Kroczek
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2015-12-31

项目摘要

项目成果

Professor Dr. Richard Kroczek的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the immune system, antigen is taken up and processed by “dendritic cells” (DC), of which an important subgroup (20%) are CD8+DC. The exact contribution of CD8+DC to antigen (cross-)presentation, an absolutely central process for the establishment of immune tolerance and generation of immunity, could not be assessed to date due to the lack of suitable experimental systems. Numerous data, however, point to a pivotal role of these CD8+DC in the development of a cytotoxic response to viruses, intracellular bacteria, and certain tumors. Based on the identification of a surface receptor, which is exclusively expressed in cross-presenting CD8+DC, we will be able to genetically delete these DC in mice and thus define their role in the immune system at steady state (tolerance) and in infection (immunity). These studies will be accompanied by numerous approaches aimed at defining the function of CD8+ DC in various organs of wild type mice. At the same time, we will identify the human counterpart of murine CD8+DC. These human DC will be phenotypically characterized and functionally tested, in particular for their capacity to (cross-)present antigen to CD8+ T cells, which are the mainstay of the cytotoxic immune defense. These basic studies will provide information which may enable us in the future to develop fundamentally new types of vaccines optimized for the induction of cytotoxic T cells directed against viral diseases and tumors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phenotypic and functional characterization of primary human lymphoid dendritic cells, with a focus on XCR1+ DC
Klonierung, biochemische und funktionelle Charakterisierung eines neuen, T-Zell-spezifischen Zelloberflächenmoleküls (8F4)
Regulation, Expression und Effektorfunktion des TRAP (CD40L)-Moleküls unter physiologischen und pathologischen Bedingungen
国内基金
海外基金
糖脂代谢重塑型金属多酚纳米药物促进CD8+ T细胞活化浸润增效PD-1抗体治疗三阴性乳腺癌的研究
  • 批准号:
    2026JJ50635
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘芙蓉
  • 依托单位:
前列腺癌CD8+ T细胞雄激素受体表达介导内分泌治疗耐药的机制研究
  • 批准号:
    JCZRLH202601667
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
Leptin通过调控MxA表达促进CD8+ T细胞活化参与白癜风发生发展的作用机制研究
  • 批准号:
    2026JJ81680
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    张慧明
  • 依托单位:
CD8+ T细胞衰老的代谢调控研究
  • 批准号:
    JCZRQNA202600019
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: